Neuromuscular blocking properties of ribostamycin (1gm), dibecacin (100 mg) and tobramycin (60mg) were studied in man during anesthesia and surgery by observing the effects of these antibiotics on muscle twitch tension. These drugs alone did not show any neuromuscular blocking action in those therapeutic doses. However, during the recovery phase of d-tubocurarine block the intravenous administration of 1 gm of ribostamycin caused a fairly rapid decrease in twitch tension. Tobramycin 60mg did not show any remarkable effect, but dibecacin 100mg produced a slight potentiat ing effect on the action of d-tubocurarine.
The median nerve was stimulated at the elbow indirectly through the subcutaneous needle electrodes with supramaximal stimuli using an electric stimulator (Nihon Kohden SEN-1101). The stimuli were square-pulses of 0.2msec duration and 25-65 volts in intensity and were delivered at a frequency of 0.2 Hz (12/min). The resultant force of adduction of the middle finger was recorded by a force-displacement transducer connected to a recorder (Nihon Kohden multipurpose polygraph).
When a steady twitch height was obtained, ribostamycin 1gm, debecacin 100mg and tobramycin 60mg were given Y. Hashimoto et al. Calcium and edrophonium were effective to reverse the block.
Lower trace: effect of 60 mg of tobramycin.
intravenously and their effects on muscle twitch were observed. These drugs were also given during the recovery period from d-tubocurarine block to determine the interaction of these drugs with d-tubocurarine.
RESULTS
No change was observed in twitch height when these antibiotics were given intravenously in therapeutic doses. However, the intravenous injection of 1 gm of ribostamycin caused a fairly rapid decrease in twitch height which had recovered to 50 to 60 per cent of the control level from d-tubocurarine block (Fig. upper trace) .
Debecacin 100mg also produced a slight potentiating effect on partial d-tubocurarine block, but 100mg of tobramycin did not show any discernible effect ( Fig. middle and lower traces) .
The enhancement of the action of d-tubocurarine by these antibotics was antagonized promptly by edrophonium and more slowly by calcium (Fig. 1) .
Generally, the dosages of antibiotics necessary to produce neuromuscular block greatly exceed the therapeutic ranges. Several situations, however, may produce possible neuromuscular blocking effect due to excessive blood concentrations of antibiotics or due to their interaction with non-depolarizing muscle relaxants.
Since the major excretion route of antibiotics is urinary, renal failure may increase the blood levels of antibiotics . The neuromuscular blocking effect is expected to be more pronounced in a patient with myasthenic state or as a result of rapid absorption of the drugs following the intraperitoneal or intrapleural instillation.
Although both calcium and neostigmine (or edrophonium) counteract the neuromuscular blocking effect of antibiotics, maintenance of an adequate ventilation should be mandatory until spontaneous respiration becomes adequate .
